344 related articles for article (PubMed ID: 29420219)
21. TUG1 knockdown ameliorates atherosclerosis via up-regulating the expression of miR-133a target gene FGF1.
Zhang L; Cheng H; Yue Y; Li S; Zhang D; He R
Cardiovasc Pathol; 2018; 33():6-15. PubMed ID: 29268138
[TBL] [Abstract][Full Text] [Related]
22. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
[TBL] [Abstract][Full Text] [Related]
23. Humoral factors secreted from adipose tissue-derived mesenchymal stem cells ameliorate atherosclerosis in Ldlr-/- mice.
Takafuji Y; Hori M; Mizuno T; Harada-Shiba M
Cardiovasc Res; 2019 May; 115(6):1041-1051. PubMed ID: 30388208
[TBL] [Abstract][Full Text] [Related]
24. Counteractive effects of omentin-1 against atherogenesis†.
Watanabe K; Watanabe R; Konii H; Shirai R; Sato K; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
Cardiovasc Res; 2016 May; 110(1):118-28. PubMed ID: 26790473
[TBL] [Abstract][Full Text] [Related]
25. Roles of the kisspeptin/GPR54 system in pathomechanisms of atherosclerosis.
Watanabe T; Sato K
Nutr Metab Cardiovasc Dis; 2020 Jun; 30(6):889-895. PubMed ID: 32409274
[TBL] [Abstract][Full Text] [Related]
26. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice.
Higashi Y; Sukhanov S; Shai SY; Danchuk S; Tang R; Snarski P; Li Z; Lobelle-Rich P; Wang M; Wang D; Yu H; Korthuis R; Delafontaine P
Circulation; 2016 Jun; 133(23):2263-78. PubMed ID: 27154724
[TBL] [Abstract][Full Text] [Related]
27. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
28. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
[TBL] [Abstract][Full Text] [Related]
29. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
[TBL] [Abstract][Full Text] [Related]
30. Endothelial Rap1 (Ras-Association Proximate 1) Restricts Inflammatory Signaling to Protect From the Progression of Atherosclerosis.
Singh B; Kosuru R; Lakshmikanthan S; Sorci-Thomas MG; Zhang DX; Sparapani R; Vasquez-Vivar J; Chrzanowska M
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):638-650. PubMed ID: 33267664
[TBL] [Abstract][Full Text] [Related]
31. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
32. Large Extracellular Vesicle-Associated Rap1 Accumulates in Atherosclerotic Plaques, Correlates With Vascular Risks and Is Involved in Atherosclerosis.
Perdomo L; Vidal-Gómez X; Soleti R; Vergori L; Duluc L; Chwastyniak M; Bisserier M; Le Lay S; Villard A; Simard G; Meilhac O; Lezoualc'h F; Khantalin I; Veerapen R; Dubois S; Boursier J; Henni S; Gagnadoux F; Pinet F; Andriantsitohaina R; Martínez MC;
Circ Res; 2020 Aug; 127(6):747-760. PubMed ID: 32539601
[TBL] [Abstract][Full Text] [Related]
33. PAR2 (Protease-Activated Receptor 2) Deficiency Attenuates Atherosclerosis in Mice.
Jones SM; Mann A; Conrad K; Saum K; Hall DE; McKinney LM; Robbins N; Thompson J; Peairs AD; Camerer E; Rayner KJ; Tranter M; Mackman N; Owens AP
Arterioscler Thromb Vasc Biol; 2018 Jun; 38(6):1271-1282. PubMed ID: 29599135
[TBL] [Abstract][Full Text] [Related]
34. IgE Contributes to Atherosclerosis and Obesity by Affecting Macrophage Polarization, Macrophage Protein Network, and Foam Cell Formation.
Zhang X; Li J; Luo S; Wang M; Huang Q; Deng Z; de Febbo C; Daoui A; Liew PX; Sukhova GK; Metso J; Jauhiainen M; Shi GP; Guo J
Arterioscler Thromb Vasc Biol; 2020 Mar; 40(3):597-610. PubMed ID: 31996021
[TBL] [Abstract][Full Text] [Related]
35. Role of endothelial cell-derived angptl2 in vascular inflammation leading to endothelial dysfunction and atherosclerosis progression.
Horio E; Kadomatsu T; Miyata K; Arai Y; Hosokawa K; Doi Y; Ninomiya T; Horiguchi H; Endo M; Tabata M; Tazume H; Tian Z; Takahashi O; Terada K; Takeya M; Hao H; Hirose N; Minami T; Suda T; Kiyohara Y; Ogawa H; Kaikita K; Oike Y
Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):790-800. PubMed ID: 24526691
[TBL] [Abstract][Full Text] [Related]
36. nSMase2 (Type 2-Neutral Sphingomyelinase) Deficiency or Inhibition by GW4869 Reduces Inflammation and Atherosclerosis in Apoe
Lallemand T; Rouahi M; Swiader A; Grazide MH; Geoffre N; Alayrac P; Recazens E; Coste A; Salvayre R; Nègre-Salvayre A; Augé N
Arterioscler Thromb Vasc Biol; 2018 Jul; 38(7):1479-1492. PubMed ID: 29794115
[TBL] [Abstract][Full Text] [Related]
37. TSP-1 (Thrombospondin-1) Deficiency Protects ApoE
Ganguly R; Khanal S; Mathias A; Gupta S; Lallo J; Sahu S; Ohanyan V; Patel A; Storm K; Datta S; Raman P
Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):e112-e127. PubMed ID: 33327743
[TBL] [Abstract][Full Text] [Related]
38. DBZ (Danshensu Bingpian Zhi), a Novel Natural Compound Derivative, Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice.
Wang J; Xu P; Xie X; Li J; Zhang J; Wang J; Hong F; Li J; Zhang Y; Song Y; Zheng X; Zhai Y
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28971954
[TBL] [Abstract][Full Text] [Related]
39. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
40. Surfactant protein-D deficiency suppresses systemic inflammation and reduces atherosclerosis in ApoE knockout mice.
Hirano Y; Choi A; Tsuruta M; Jaw JE; Oh Y; Ngan D; Moritani K; Chen YR; Tam S; Li Y; Vasilescu DM; Hogg JC; Francis G; Bernatchez P; Man SP; Sin DD
Cardiovasc Res; 2017 Aug; 113(10):1208-1218. PubMed ID: 28472244
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
